Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Kiniksa Pharmaceuticals, Ltd. (KNSA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 52 shares @ $16.01, valued at $832.5
Exercised 175 options to buy @ $0
07/27/2023 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 5,200 shares @ $18.01, valued at $93.7k
Sold 16,168 shares @ $19.25, valued at $311.2k
Sold 7,632 shares @ $19.69, valued at $150.3k
Exercised 29,000 options to buy @ $1.86, valued at $53.9k
07/03/2023 4 Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
07/03/2023 4 McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
07/03/2023 4 Levy Richard S (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
07/03/2023 4 Popovits Kimberly J (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
07/03/2023 4 Cole G Bradley (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
07/03/2023 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
06/08/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 8,746 shares @ $0
Granted 52,472 options to buy @ $15.19, valued at $797k
Granted 52,472 options to buy @ $15.19, valued at $797k
06/08/2023 4 Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
06/08/2023 4 Popovits Kimberly J (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
06/08/2023 4 Levy Richard S (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
06/08/2023 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
06/08/2023 4 Cole G Bradley (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
06/08/2023 4 McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
04/03/2023 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 38,974 options to buy @ $10.76, valued at $419.4k
Granted 6,496 options to buy @ $0
04/03/2023 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 20,459 options to buy @ $10.76, valued at $220.1k
Granted 10,230 options to buy @ $0
04/03/2023 4 Moat Ross (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 38,668 options to buy @ $10.76, valued at $416.1k
Granted 6,445 options to buy @ $0
04/03/2023 4 Ragosa Mark (CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 42,050 options to buy @ $10.76, valued at $452.5k
Granted 7,000 options to buy @ $0
04/03/2023 4 Tessari Eben (COO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 42,544 options to buy @ $10.76, valued at $457.8k
Granted 7,091 options to buy @ $0
04/03/2023 4 Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 155,500 options to buy @ $10.76, valued at $1.7M
Granted 25,925 options to buy @ $0
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 704 shares @ $9.56, valued at $6.7k
Paid exercise price by delivering 221 shares @ $11.46, valued at $2.5k
Paid exercise price by delivering 635 shares @ $11.12, valued at $7.1k
Exercised 774 options to buy @ $0
Exercised 2,163 options to buy @ $0
03/20/2023 4 Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 1,929 shares @ $11.46, valued at $22.1k
Paid exercise price by delivering 3,523 shares @ $11.12, valued at $39.2k
Exercised 6,569 options to buy @ $0
Exercised 12,002 options to buy @ $0
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 52 shares @ $14.23, valued at $740
Exercised 175 options to buy @ $0
09/06/2022 4 Moat Ross (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 360 shares @ $9.56, valued at $3.4k
Paid exercise price by delivering 563 shares @ $11.44, valued at $6.4k
Granted 59,460 options to buy @ $11.97, valued at $711.7k
Granted 9,908 options to buy @ $0
Exercised 995 options to buy @ $0
09/06/2022 4 Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 1,929 shares @ $11.44, valued at $22.1k
Granted 239,795 options to buy @ $11.97, valued at $2.9M
Granted 39,967 options to buy @ $0
Exercised 6,569 options to buy @ $0
09/06/2022 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 507 shares @ $11.44, valued at $5.8k
Granted 59,930 options to buy @ $11.97, valued at $717.4k
Granted 9,990 options to buy @ $0
Exercised 1,725 options to buy @ $0
09/06/2022 4 Ragosa Mark (CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 547 shares @ $11.44, valued at $6.3k
Granted 64,660 options to buy @ $11.97, valued at $774k
Granted 10,777 options to buy @ $0
Exercised 1,861 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy